the use case / value proposition for IHL-675A gets stronger month by month the deeper into the research we go...
La Trobe has it going on
![smile.png](https://hotcopper.com.au/images/smilies/smile.png)
world leading /best in class research imo, ..... vaccines were always a short term solution only -
14/06/21
![https://hotcopper.com.au/data/attachments/3271/3271337-8f1daaf8e83e737207baf2ec94a1c2af.jpg](https://hotcopper.com.au/data/attachments/3271/3271337-8f1daaf8e83e737207baf2ec94a1c2af.jpg)
and prior to ICU ..and any required patient intubation - as a potential prophylactic pro active / pre emptive treatment -
all the research and empirical evidence to date indicates major damage has potentially already been incurred by the time ICU has been required...
![https://hotcopper.com.au/data/attachments/3271/3271348-cdd4cb81749f39074b2e4582557a10da.jpg](https://hotcopper.com.au/data/attachments/3271/3271348-cdd4cb81749f39074b2e4582557a10da.jpg)
![https://hotcopper.com.au/data/attachments/3271/3271351-3d2e4526063513f85964dc95d65bf1c1.jpg](https://hotcopper.com.au/data/attachments/3271/3271351-3d2e4526063513f85964dc95d65bf1c1.jpg)
if timing is everything then what IHL-675A potentially brings to the table can't come soon enough imo
news eagerly awaited as always - and it will be company making imo
GLA